- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 12.06. | Aditxt Signs Agreement Valuing Ignite Proteomics At Approximately $150 Million | 6 | pulse2.com | ||
| 11.06. | Copley Acquisition to merge with Ignite Proteomics | 3 | Seeking Alpha | ||
| 11.06. | Copley Acquisition to merge with Ignite Proteomics at $150m value | 1 | Investing.com | ||
| 11.06. | Copley Acquisition Corp (NYSE: COPL) and Ignite Proteomics Announce Business Combination Agreement to Advance Precision Oncology | 342 | GlobeNewswire (Europe) | Ignite Proteomics is a pioneer in delivering pathway-level protein analytics designed to guide precision oncology. HONG KONG, June 11, 2026 (GLOBE NEWSWIRE) -- Copley Acquisition Corp (NYSE: COPL)... ► Artikel lesen | |
| 09.06. | Aditxt to spin off Ignite Proteomics in $150M public market deal; shares up | 2 | Seeking Alpha | ||
| 09.06. | Aditxt subsidiary Ignite Proteomics to go public via SPAC deal | 4 | Investing.com | ||
| 31.03. | IMAC Holdings, Inc. - 15-12G, Securities registration termination | 3 | SEC Filings | ||
| 19.03. | IMAC Holdings, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| IMAC HOLDINGS Aktie jetzt für 0€ handeln | |||||
| 19.03. | Aditxt beruft Jeff Busch an die Spitze der Tochtergesellschaft Ignite Proteomics | 1 | Investing.com Deutsch | ||
| 19.03. | Aditxt names Jeff Busch CEO of Ignite Proteomics subsidiary | 2 | Investing.com | ||
| 13.03. | Aditxt acquires Ignite Proteomics in $36M preferred stock deal; shares down | 1 | Seeking Alpha | ||
| 13.03. | Aditxt acquires precision oncology firm Ignite Proteomics | 2 | Investing.com | ||
| 13.03. | Aditxt übernimmt Präzisionsonkologie-Unternehmen Ignite Proteomics | 2 | Investing.com Deutsch | ||
| 27.02. | IMAC Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 18.02. | IMAC Holdings, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 30.01. | IMAC Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 16.01. | IMAC Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 29.12.25 | IMAC Holdings, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 10.09.25 | IMAC Holdings, Inc.: Ignite Proteomics Announces Collaboration with Inova Health on a Biomarker Study for Late-Stage Cancers | 233 | GlobeNewswire (Europe) | The First Precision Oncology Trial to Use a Functional Proteomics and Phosphoproteomics Assay for Treatment Decision Making in a Pan-Tumor Study Golden, CO, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Ignite... ► Artikel lesen |
19 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| PLUS THERAPEUTICS | 3,650 | +2,53 % | Plus Therapeutics wins Elevance Health coverage deal | ||
| ASENSUS SURGICAL | - | - | Karl Storz to fully integrate Asensus, discontinue Senhance, Luna robots | ||
| MEDIVOLVE | - | - | Medivolve Inc (2): OSC cites Bharti, Said for disclosure failures | ||
| LIFEWARD | 7,200 | 0,00 % | Lifeward Ltd.: Lifeward Appoints Dr. Keith D. Rose as Chief Medical Officer to Support Expansion of Neurorehabilitation Portfolio and Advance Biomed Platform | Veteran physician- medical affairs and clinical research leader brings 30 years of rehabilitation medicine experience and deep expertise in neuroscience- mobility technologies, and metabolic disease... ► Artikel lesen | |
| IMUNON | 1,560 | -0,64 % | Imunon, Inc.: IMUNON Announces Data Monitoring Committee Recommends Continuation of Phase 3 OVATION 3 Study Without Modification | On track for enrollment of 80 participants by Q1 2027 Trial is supported by Phase 2 results showing significant improvement in overall survival in women with newly diagnosed advanced ovarian cancer... ► Artikel lesen | |
| ROCKWELL MEDICAL | 0,605 | +4,31 % | ROCKWELL MEDICAL, INC. - 8-K, Current Report | ||
| VIRIDIAN THERAPEUTICS | 15,800 | +0,64 % | XFRA 1S1: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| SINTX TECHNOLOGIES | 1,930 | +0,52 % | SINTX Technologies, Inc.: SINTX Technologies Announces Receipt of More Than $3.2 Million in Contract Manufacturing Purchase Orders | SALT LAKE CITY, Utah, June 22, 2026 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) ("SINTX" or the "Company"), a leader in advanced silicon nitride ceramics and advanced material technologies... ► Artikel lesen | |
| AETHLON MEDICAL | 0,890 | +1,94 % | Aethlon Medical study links device to Long COVID markers | ||
| NEURONETICS | 1,090 | -8,02 % | Neuronetics, Inc. - 8-K, Current Report | ||
| STAGEZERO LIFE SCIENCES | 0,028 | -100,00 % | StageZero Life Sciences Ltd.: StageZero Announces Partial Revocation of Failure to File Cease Trade Order and Proposed Financing | ||
| ARCH THERAPEUTICS | - | - | Arch Therapeutics, Inc. - 15-12G, Securities registration termination | ||
| HVIVO | 0,094 | -1,57 % | hVIVO PLC - Holding(s) in Company | ||
| BRIGHTSPRING HEALTH SERVICES | 68,98 | 0,00 % | BrightSpring Health Services, Inc. Reports First Quarter 2026 Financial Results and Increases Full Year 2026 Guidance | LOUISVILLE, Ky., May 01, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| PROGYNY | 28,510 | 0,00 % | Truist raises Progyny stock price target to $33 on growth outlook |
Das Unternehmen IMAC HOLDINGS INC kann der Branche Gesundheitswesen zugeordnet werden.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu IMAC HOLDINGS INC finden Sie auf Wallstreet Online.